Giant cell arteritis, also referred to as ‘temporal arteritis’, is the most common vasculitis affecting persons over 50 years old. 1, 2 The disease preferentially affects large- and medium ...

In addition to other acute or chronic inflammatory conditions (eg, temporal arteritis as suspected in this case, isolated polymyalgia rheumatica, gout, pseudogout, inflammatory bowel disease, etc ...

Patients from lower socioeconomic status (SES) backgrounds are more likely to undergo temporal artery biopsy (TAB) but are not at increased risk for biopsy-confirmed giant cell arteritis (GCA), ...

Giant-cell arteritis typically involves extracranial branches of the aorta, such as the temporal and vertebral arteries. Temporal arteritis and polymyalgia rheumatica often coexist, and systemic ma ...

Giant cell arteritis, also called temporal arteritis, is a disease that causes your arteries -- blood vessels that carry oxygen from your heart to the rest of your body -- to become inflamed. It ...

Both giant-cell arteritis and polymyalgia rheumatica are immune-mediated diseases that are treated with glucocorticoids, with higher doses used for giant-cell arteritis. Prompt initiation of high d ...

Temporal arteritis, also called giant cell arteritis, is the inflammation of large- and medium-sized blood vessels. The exact cause is not understood, but it does seem to have elements of an ...

The US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

She was initially started on steroids for presumed giant cell arteritis (GCA), and a rush temporal artery biopsy was performed and appeared grossly nodular so she was treated with a 3-day course ...

SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck.

KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell arteritis, Mercy Bechtold, MD, said during her presentation at Kiawah Eye.